Evidence map›Paper›PMID 31080520›Full record

ArticleWiley interdisciplinary reviews. Computational molecular science

Perspective on computational simulations of glycosaminoglycans.

Balaji Nagarajan, Nehru Viji Sankaranarayanan, Umesh R Desai

Abstract read
In one paragraph

Article in Wiley interdisciplinary reviews. Computational molecular science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. 3-Computational and structural biotechnology journal · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Advancing Solutions to the Carbohydrate Sequencing Challenge.Journal of the American Chemical Society · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Balaji Nagarajan *Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA 23298, USA.
Nehru Viji Sankaranarayanan *Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA 23298, USA.
Umesh R DesaiInstitute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA 23298, USA.
Virginia Commonwealth University · US

Funding

Therapeutic assessment of synthetic heparin sulfates in transplantation modelsP01HL107152 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DESAI, UMESH RAMANLAL · 2011 to 2017
$15.8M
Glycans in Blood Homeostasis and DiseaseK12HL141954 · NHLBI · VERSITI WISCONSIN, INC. · PI DAHMS, NANCY M., DESAI, UMESH RAMANLAL · 2018 to 2022
$4.9M
Dual Direct Inhibitors of Thrombin and Factor XaR01HL090586 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DESAI, UMESH RAMANLAL · 2009 to 2018
$3.9M
Advanced Skills Development in Glyco-Hematology and Glyco-OncologyR25HL128639 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DESAI, UMESH RAMANLAL · 2015 to 2019
$613k
NHLBI NIH HHS K12 HL141954NHLBI NIH HHS P01 HL107152NHLBI NIH HHS R01 HL090586NHLBI NIH HHS R25 HL128639
6 · The paper itself

Abstract

Glycosaminoglycans (GAGs) represent a formidable frontier for chemists, biochemists, biologists, medicinal chemists and drug delivery specialists because of massive structural complexity. GAGs are arguably the most complex, natural linear biopolymers with theoretical diversity orders of magnitude higher than proteins and nucleic acids. Yet, this diversity remains generally untapped. Computational approaches offer major routes to understand GAG structure and dynamics so as to enable novel applications of these biopolymers. In fact, computational algorithms, softwares, online tools and techniques have reached a level of sophistication that help understand atomistic details of conformational variation and protein recognition of individual GAG sequences. This review describes current approaches and challenges in computational study of GAGs. It presents a history of major findings since the earliest mention of GAGs (the 1960s), the development of parameters and force fields specific for GAGs, and the application of these tools in understanding GAG structure-function relationship. This review also presents a section on how to perform simulation of GAGs, which is directed toward researchers interested in entering this promising field with potential to impact therapy.

Indexed as

Force fieldsFree energyGlycosaminoglycanshydrogen bondsMolecular dynamicsSolvent effectsTorsion

Identifiers

PMID31080520
PMCPMC6504973
OpenAlexW2890505952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.